In part 1 of this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the challenges faced by women with diabetes who are pregnant and using an insulin pump.

In part 2 of this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the findings of the prenatal study of women with diabetes, both before pregnancy and during. Also, the impact of the CGM on pregnancy.

In part 3, the conclusion of this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the unique aspects of a new trial that studies the artificial pancreas and the benefits for people on multiple daily injections who may not want to use a pump.

Globally, ambient PM_2.5 contributed to about 3.2 million incident cases of diabetes

Sometimes it is more important how you say something than what you are trying to say. For example, if you tell someone, “You have a face that would stop a clock,” you will likely get a slap in the face or a look of scorn, but if you say, “You …

Key ADA poster summaries include liraglutide in type 1 diabetes, oral semaglutide, bottled water's association with type 2 diabetes, & SGLT-2 combo LIK066.

ADA 2018 abstracts of interest include Entresto for the Treatment of Diabetic Peripheral Neuropathy; Oral Contraceptive Associated with Postmenopausal Diabetes; Glucokinase as Adjunct Therapy in People with Type 1 Diabetes, and more.

Overview from a presentation at the 2018 American Diabetes Associations 78th Scientific Sessions.

The “artificial pancreas” provides glucose control for non-critically ill patients

A single dose of BCG vaccine appears to decrease progression of new onset diabetes.